October 2009

Articles

EDITOR'S PAGE

RESEARCH RESULTS

SURGICAL PEARLS

TECHNOLOGY TODAY

COMPLICATIONS: FOCUS ON THE BLEB

  • Bleb Leaks

    Experience-based advice on management.

    By Donald L. Budenz, MD, MPH

  • Hypotony due to an Overactive Bleb

    How to proceed when filtering surgery is too effective.

    By Amy Badger, MD; Todd Perkins, MD; Geoffrey T. Emerick, MD; and Michael C. Stiles, MD

  • Managing a Failing Filtering Bleb

    An understanding of wound healing and predisposing risk factors will help surgeons in their rescue efforts.

    By Nils A. Loewen, MD, PhD, and James C. Tsai, MD

  • Bleb-Related Infections

    Diagnosis, risk factors, and the treatment of blebitis and bleb-related endophthalmitis.

    By JoAnn A. Giaconi, MD

CHALLENGING CASES

PRACTICE POINTERS

  • Adopting New Technology

    Guidelines for incorporating new diagnostic and surgical techniques into an established glaucoma practice.

    By Steven D. Vold, MD

INSIDE EYETUBE.NET

View All News >
News
Study Identifies Valid Glaucoma Screening Strategies

Investigators from South Africa evaluated six glaucoma tests to determine which were suitable for use in the United Nations' Vision 2020 screening programs.1 The participants in the study included normal controls (32 individuals r... more >

News
Company Introduces High-Resolution Endoscopes

Endo Optiks, Inc. (Little Silver, NJ), launched a series of high-resolution microendoscopes during the 2009 ESCRS meeting in Barcelona, Spain. These instruments are approved in the United States for use during endoscopic cyclophot... more >

News
Abbott to Acquire Visiogen

Abbott (Abbott Park, IL) has announced a definitive agreement to acquire Visiogen, Inc. (Irvine, CA), for $400 million in cash. The acquisition will provide Abbott with Visiogen's Synchrony accommodating IOL, which is currently un... more >

News
Preservative-Free Drug Relaunched in US

Aton Pharma, Inc. (Lawrenceville, NJ), has launched a new educational, distribution, sampling, and reimbursement program for preservative-free Timoptic Ocudose (timolol maleate). Earlier this year, the company acquired the exclusi... more >

advertisement

TOP 5 ARTICLES FROM OCTOBER 2009